A Clinical Trial Evaluating the Pan-vascular Interventional Robotic System for Panvascularization Interventional Surgery

Shenzhen Institute of Advanced Biomedical Robot

Status: Not yet enrolling

Conditions: Percutaneous Coronary Intervention

Treatments: Device: Pan-vascular interventional robotic system; Procedure: Traditional artificial percutaneous coronary intervention

Study type: Interventional

Funder types: Industry

Identifiers

NCT06502938

CAPTAIN-C

Details and patient eligibility

About

The purpose of this prospective, randomized, open, parallel controlled, multicenter trial is to investigate the efficacy and safety of the pan-vascular interventional robotic system for percutaneous coronary intervention (PCI). Investigators will evaluate clinical success, technical success, and record intraoperative data (PCI time, total operating time, contrast agent dose, radiation exposure dose, etc.). All subjects were followed up on the day of surgery, before discharge and 1 month after surgery to observe the safety indicators.

Enrollment: 159 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. General Inclusion criteria:

2. 18 years old ≤ age ≤85 years old;

3. have a clinical indication for PCI (clinical evidence of ischemic heart disease or a positive functional study);

4. Subject or guardian can understand the purpose of the experiment and sign informed consent voluntarily Book and willing to cooperate to complete the follow-up.

5. Angiographic inclusion criteria:

6. The stenosis degree of visual target lesion ≥50%;

7. 2.5mm≤ Visual target vessel diameter ≤4.0mm;

8. Visual target lesions ≤38mm in length, or successive small lesions that can be completely covered by a single stent;

9. Target lesions to be treated intraoperatively cannot be treated in stages.

Exclusion criteria

1. General exclusion criteria 1)A stroke occurred within 30 days prior to surgery; 2)Percutaneous coronary intervention was performed within 72 hours before surgery; 3)Acute myocardial infarction, cardiogenic shock, or infarction occurred within 48 hours before surgery Received CPR; 4)Other cardiac procedures (such as aortic valve placement) are scheduled within 30 days of surgery Coronary artery bypass grafting, etc.); 5)Pregnant or lactating female subjects; 6)Severe hepatic or renal insufficiency or bleeding tendency; 7)Known allergy to interventional device materials and their coatings, or allergy to contrast agents; 8)Severe stenosis, occlusion of blood vessels at the intended puncture site, or local skin infection and uncontrollable; 9)Are participating in other interventional clinical studies, and have not completed the evaluation of the primary endpoint of the relevant study; 10)Participants who had other contraindications for interventional therapy or were judged by the investigator to be unsuitable for participation in the study;
2. Angiographic exclusion criteria 1)The TIMI blood flow grade of the target lesion was < 2; 2)Treatment requiring intrastent restenosis, or prior placement of a stent in the target vessel near both ends of the target lesion; 3)Severe tortuosity or severe calcification of blood vessels; 4)There's an intracavitary thrombus; 5)In addition to balloon forming and stent implantation, other treatments (such as atheromatectomy, rotary grinding, laser ablation, etc.) are also required at the same time; 6)The researchers determined that percutaneous coronary intervention was not suitable for robotic assistance or that there might be high risks in the process.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

159 participants in 2 patient groups

Pan-vascular interventional robotic system group

Experimental group

Description:

Pan-vascular interventional robotic system assisted PCI

Treatment:

Device: Pan-vascular interventional robotic system

Artificial control group

Experimental group

Description:

Traditional artificial percutaneous coronary intervention

Treatment:

Procedure: Traditional artificial percutaneous coronary intervention